Theravet SA ALVET.PA

€0.08

Last Updated: Jan 27, 12:00 AM·XPAR

ALVET.PA Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: September 13, 2024

Report Source: 2023 Annual Report

Analyst's Ratings for Theravet SA (ALVET.PA)

Based on 9 analysts giving stock ratings to Theravet SA in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
33
Buy
56
Hold
11
Sell
0
Strong Sell
0
Theravet SA

Theravet SA. Stock Analysis ALVET.PA

France Health Care Nano Cap Report:
EGEIRO Pharma is a veterinary biotech company, which specializes in the development and production of treatments for osteoarticular diseases in cats, dogs, and horses. The company is headquartered in Charleroi, Hainaut. The company went IPO on 2021-06-17. The firm develops treatments to improve the standard of life of pets suffering from orthopedic, osteoarticular, joint and bone diseases. The company focuses on the indications and applications of osteoarthritis, ligament, tendon injuries and bone surgery in cats and dogs as well as horses. The company develops new treatments and veterinary products specifically adapted to pets from formulation to production through preclinical, clinical and regulatory evaluation. The company is situated in the places like Belgium and abroad (France, Switzerland, United Kingdom and United States).
Read More

Theravet SA (ALVET.PA) Chart

Key Statistics of Theravet SA (ALVET.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.08€0.09

Today's Open

€0.08

Volume

2040.00

P/E Ratio (TTM)

-

52 Week Range

€0.08€0.11

Market Cap

290.00K

Avg. Volume

18.47K

Dividend Yield

-

Financial Metrics & Statements of Theravet SA (ALVET.PA)

Community-Curated Collections with Theravet SA (ALVET.PA) ( With ALVET.PA )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Theravet SA (ALVET.PA)

  • According to Musaffa’s Shariah screening methodology, Theravet SA (ALVET.PA) is currently classified as HALAL as of September 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.